TAVI: Edwards CEO says Sapien 3 could hit U.S. market this year

Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-generation Sapien 3 replacement heart valve this year. Edwards LifesciencesNews Well, MassDevice.com Earnings Roundup, 2015, Q1, Replacement Heart Valvesread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news